Citation Impact
Citing Papers
Allogeneic Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation
2008
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
Randomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer
2007
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Short chain fatty acids in human large intestine, portal, hepatic and venous blood.
1987 Standout
Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device
1974
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
2008 Standout
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer
2007
EGFR Antagonists in Cancer Treatment
2008 Standout
Pancreatic cancer
2004 Standout
A view on drug resistance in cancer
2019 StandoutNature
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Comparing antibody and small-molecule therapies for cancer
2006
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody
2007
Lung Cancer
2008 Standout
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis
2014 Standout
Advanced pancreatic carcinoma: current treatment and future challenges
2010
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Pancreatic cancer
2016 Standout
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019 StandoutNobel
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Pancreatic Adenocarcinoma
2014 Standout
Decreased membrane mechanical stability and in vivo loss of surface area reflect spectrin deficiencies in hereditary spherocytosis.
1988 StandoutNobel
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Cetuximab in advanced non-small cell lung cancer
2006
Biodegradation of malathion by Acinetobacter johnsonii MA19 and optimization of cometabolism substrates
2009
Biodegradation aspects of Polycyclic Aromatic Hydrocarbons (PAHs): A review
2009 Standout
The Application of Biotechnology to the Treatment of Wastes Produced from the Nuclear Fuel Cycle: Biodegradation and Bioaccumulation as a Means of Treating Radionuclide-Containing Streams
1991
Reductions of erythrocyte membrane viscoelastic coefficients reflect spectrin deficiencies in hereditary spherocytosis.
1988 StandoutNobel
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Treatment of organic pollution in industrial saline wastewater: A literature review
2006 Standout
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
1996 Standout
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
2010
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
Phytoremediation: A Novel Strategy for the Removal of Toxic Metals from the Environment Using Plants
1995 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Glucose-6-phosphate dehydrogenase deficiency
2000
G6PD: Population genetics and clinical manifestations
1996
Pancreatic Cancer
2010 Standout
Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer
2007
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Emerging drugs for non-small-cell lung cancer
2007
Immunotherapy for pancreatic cancer — science driving clinical progress
2005
Pancreatic cancer
2011 Standout
Degradation of Xenobiotics by White Rot Fungi
1991
The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC‐205/CD205 Receptor on Dendritic Cells
2009 StandoutNobel
General principles of tumor immunotherapy : basic and clinical applications of tumor immunology
2007
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer
2007
Geometric and Electronic Structure/Function Correlations in Non-Heme Iron Enzymes
1999 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Synergistic Antipancreatic Tumor Effect by Simultaneously Targeting Hypoxic Cancer Cells With HSP90 Inhibitor and Glycolysis Inhibitor
2008
Biodegradation of Chemicals of Environmental Concern
1981 Science
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
2006 Standout
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Effects of inherited membrane abnormalities on the viscoelastic properties of erythrocyte membrane
1987
Salvage Therapy in Patients with Advanced Non-small Cell Lung Cancer
2006
Molecular Mechanisms of Resistance to Therapies Targeting the Epidermal Growth Factor Receptor
2005
Tumor Growth Inhibition with Cetuximab and Chemotherapy in Non–Small Cell Lung Cancer Xenografts Expressing Wild-type and Mutated Epidermal Growth Factor Receptor
2007
Application of Continuous Culture Technology for the Development of Explosives‐degrading Microorganismsa
1997 StandoutNobel
Dependence of the mechanical properties of actin/α-actinin gels on deformation rate
1987 Nature
Molecular correlates of gefitinib responsiveness in human bladder cancer cells
2007
Bacterial dehalogenases: biochemistry, genetics, and biotechnological applications
1994
Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial
2005
Involvement of Phospholipids in the d-Glucose Uptake Activity of Isolated Human Erythrocyte Membranes
1972
Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database
2016
Plasmid-Assisted Molecular Breeding: New Technique for Enhanced Biodegradation of Persistent Toxic Chemicals
1981 Science
Dynamic Kinetic Resolution of Racemic β-Haloalcohols: Direct Access to Enantioenriched Epoxides
2008 StandoutNobel
Salvage Therapy in Patients with Advanced Non-small Cell Lung Cancer
2006
Glucose-6-phosphate dehydrogenase deficiency
2008 Standout
The Pathogenesis of Atherosclerosis
1976 Standout
Internal cell manipulation using infrared laser traps.
1989 StandoutNobel
The Role of Acidic Phospholipids in Glucagon Action on Rat Liver Adenylate Cyclase
1973 StandoutNobel
Microbial degradation of pollutants at high salt concentrations
1992
Increased EGFR Gene Copy Number Detected by Fluorescent In Situ Hybridization Predicts Outcome in Non–Small-Cell Lung Cancer Patients Treated With Cetuximab and Chemotherapy
2008
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
2010
Platelet Physiology and Abnormalities of Platelet Function
1975 Standout
Pancreatic Adenocarcinoma Clinical Practice Guidelines in Oncology
2005
Platelet Physiology and Abnormalities of Platelet Function
1975
Oxidation of Persistent Environmental Pollutants by a White Rot Fungus
1985 StandoutScience
Works of Arthur Rosenberg being referenced
A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma
2006
The elasticity of spectrin-actin gels at high protein concentration.
1985
Microbial metabolism of 2,4,5-trichlorophenoxyacetic acid in soil, soil suspensions, and axenic culture
1980
Pseudomonas halodurans sp. nov., a halotolerant bacterium
1983
2,4,5-Trichlorophenoxyacetic acid (2,4,5-T) decomposition in tropical soil and its cometabolism by bacteria in vitro
1980
Microbial cleavage of various organophosphorus insecticides
1979
Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial
2004
Platelet‐Function Studies in Patients with Glucose‐6‐Phosphate Dehydrogenase Deficiency
1974
Multicenter Phase I/II Study of Cetuximab With Paclitaxel and Carboplatin in Untreated Patients With Stage IV Non–Small-Cell Lung Cancer
2005
Structural and Compositional Changes in the Red Cell Membrane during Clostridium welchii Infection
1971
Vitamin B12 Uptake by Human Small Bowel Homogenate and its Enhancement by Intrinsic Factor
1969